24 Anticoagulants Flashcards

1
Q

In what form are coagulation factors present in blood?

A
  • Inactive zygomens
  • Serine proteases
  • Cofactors
    • Calcium- important cofactor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where are heparins produced naturally in the body?

A
  • Mast cells
  • Vascular endothelium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do we acquire heparins for pharmaceutical use?

A
  • Porcine intestinal mucosa
  • Bovine lung
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do heparins work? (general terms?

A

Enhance antithrombin III activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Unfractionated heparin has an unpredictable elimination. What is its half life like at high doses? What is its elimination like at low doses?

A

Low doses: half-life= 30 mins

High doses: half life= 2hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the mechanism of action for unfractionated heparin?

A

Binds to antithrombin III (ATIII)

Conformational change and increased activity of ATIII

  • Heparin binds ATIII and thrombin (IIa)
    • Catalyses inhibition of IIa
  • ATIII binds to Xa and inhibits it
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Give 2 examples of low molecular weight heparins.

A
  1. Dalteparin
  2. Enoxaparin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How are low molecular weight heparins normally administered?

A

Sub cutaneous

(Enoxaparin i.v. in ACS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the bioavailabilty of LMWHs like? What are their half-lives like?

A
  • Bioavailability= 90%
  • Half life= 2+hrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why do low molecular weight heparins have a more predictable dose response than Unfractionated heparin?

A
  • Absorbed more uniformly
  • Do not bind to endothelial cells, plasma proteins, macrophages
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Outline the mechanism of action for low molecular weight heparins.

A

Enhance ATIII activity - inhibit factor Xa specifically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fondaparinux is a synthetic pentasaccharide.

  • How does it work?
  • How is it administered?
  • What is it’s half life?
A
  • How does it work?
    • Like LMWH
    • Binds to ATIII
      • Selectively inhibits Xa
  • How is it administered?
    • S.C
  • What is it’s half life?
    • 18hrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do we monitor Unfractionated Heparin?

A

aPTT (activated partial thromboplastin time)

Dose titrated against this value

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When might UFH be used instead of LMWH?

A

UFH=

  • severe renal impairment
  • fine control
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the indications for heparins? (3)

A
  1. Venous thromboembolism
    1. Prevention
      1. Perioperative prophylaxis
    2. DVT and PE
      1. Initally and long term in some patients
    3. Cancer related VTE
  2. Pregnancy (doesn’t cross placenta)
    1. Monitored with caution
  3. ACS
    1. Reduce recurrence/extension of coronary artery thrombosis
      1. STEMI
      2. NSTEMI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

State some of the adverse reactions for heparins.

A
  1. Bruising/bleeding
    1. Site of injection, GI, epistaxis
  2. Hepatic/renal impairment
    1. Elderly/those with carcinoma
  3. HIT (Heparin induced thrombocytopenia)
    1. 1/100- UFH 1/1000- LMWH
    2. Autoimmune response 2-14 days after initiation
      1. Antibodies to heparin platelet factor 4 complex
  4. Hyperkalaemia
    1. Inhibition of aldosterone secretion
  5. Osteoporosis
    1. Rare long-term use
    2. More prevalent in pregnancy
17
Q

What drug can we use as heparin reversal? How does it work?

A

Protamine sulphate

18
Q

Outline the mechanism of action of warfarin.

A

Vitamin K antagonist

  • Inhibit activation of vitamin k dependent clotting factors
    • Inhibits conversion of vitamin K epoxide to vitamin K (active reduced form)
      • Competitive inhibitor of VKOR

Clotting factors (hepatic synthesis) requiring active vitamin K as co-factor:

  • II
  • VII
  • IX
  • X
19
Q

What is the half life like for warfarin?

A

36-48hrs

20
Q

State some of the indications for the use of warfarin: (3)

A
  1. Venous thromboembolism
    1. PE
    2. DVT and secondary prevention
    3. Superficial vein thrombosis
  2. AF
    1. w./ high risk of stroke
  3. Heart valve replacement

(Longer term anticoagulation compared with heparins)

(May require heparin cover if required immediately)

21
Q

What is the bioavailability like for warfarin if taken orally? Why is there inter individual variability?

A

95%

Interindividual variability due to:

  • CYP2C9 polymorphs
  • [Plasma] does not correlate directly with clinical effect
  • Warfarin- racemic mixture
    • Enantiomers- different potency and metabolised differently
  • Response varies by vitamin K intake

–> MONITORING REQUIRED due to variation in patient response

INR used to monitor

22
Q

State the adverse drug reactions to warfarin that can occur.

A
  1. Bleeding
    1. Epistaxis
    2. Spontaneous retroperitoneal bleeding
23
Q

When initiating or temprarily stopping warfarin, what bridging therapy may be required?

A

LMWH

24
Q

What can we use as warfarin reversal? (2)

A
  1. Vitamin K1
  2. Prothrombin complex concentrate (i.v.) (PCC)

STOP warfarin

25
Q

Warfarin has a huge number of drug interactions. State the important interactions to be aware of. (most enhance anticoagulation)

A
  • Inhibition of hepatic metabolism (esp CYP2C9)
    • Amiodarone
    • Clopidogrel
    • Intoxicating dose of alcohol
    • Quinolone
    • Metronidazole
  • Reduce vitamin K- eliminate gut bacteria involved in production
    • Cephalosporins
  • Displacement of warfarin from plasma albumin
    • NSAIDs
    • Drugs decreasing GI absorption of vitamin K
  • Acceleration of warfarin metabolism (decrease INR)
    • barbiturates
    • phenytoin
    • rifampicin
    • St Johns Wort
26
Q

DOAC stands for direct acting oral anticoagulant. Name the 3 DOACs that inhibit free Xa and that bound to ATIII.

A
  1. Apixaban
  2. Edoxaban
  3. Rivaroxaban
27
Q

What is the half life like for DOACs?

A

Xa inhibitor- Half-life= 10hrs

IIa inhibitors- Half-life= 9hrs

28
Q

Name the DOAC that is a direct competitive thrombin inhibitor (IIa) (both circulating and thrombus bound).

A

Dabigatran

29
Q

Can warfarin cross the placenta?

A

Yes- don’t use - esp 1st and 3rd trimestres

30
Q

What are the advantages and disadvantages of DOACs compared to other anticoagulants?

A

Advantages:

  • Less frequent interactions than warfarin
  • Lower intracranial bleed risk
  • Require less monitoring
  • Oral administration
  • Standard dosing
  • Little info on pregancy effect- avoid

Disadvantages

  • Still need caution- GI bleeding
  • Dabigatran contraindicated in low creatinine clearance
  • Affected by CYP inhibitors and inducers
    • [plasma] reduced by carbamazepine, phenytoin and barbiturates
    • [plasma] increased by macrolides

(Antidotes are now available)